PHAREX, s.r.o.
ActiveKey figures
Key figures
2025Dividends
calculatedDistributed as dividends 250 000 € (9 % of distributable profit).
In addition, equity decreased by 2 815 € other than from retained earnings — e.g. a share capital reduction, a payout from other funds or a revaluation. The open data does not show whether this was a payout to shareholders.
Summary: PHAREX, s.r.o.
What kind of company is it?
PHAREX, s.r.o. (IČO 44073437) is a limited liability company (s.r.o.). The company was incorporated in 2008 and has existed for 18 years. Registered office according to the register: Bystrička. Main activity according to the Statistical Office: veľkoobchod s farmaceutickým a zdravotníckym tovarom (SK NACE 4646). Size category by number of employees: 10–19 employees.
Who runs the company and who owns it?
The company has one statutory representative. According to the register, the company has one shareholder. The registered capital is 6 639 €.
How is the company doing financially?
Revenue for 2025 was 21 053 227 €, up 6,1 % on the previous year (19 838 973 €). This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 297 426 € (1,4 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 879 354 €. At the end of 2025 the company had total assets of 5 075 670 € and equity of 2 861 144 € (equity ratio 56,4 %).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 19. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 17 925 242 | 16 753 681 | 16 453 361 | 19 838 973 | 21 053 227 |
| Profit for the reporting year | 299 216 | 194 145 | 184 460 | 389 034 | 297 426 |
| Retained earnings of previous periods | 1 768 350 | 2 067 566 | 2 261 711 | 2 446 171 | 2 585 205 |
| Total assets | 4 648 578 | 4 746 615 | 4 696 487 | 5 143 957 | 5 075 670 |
| Total liabilities | 2 593 756 | 2 502 311 | 2 226 794 | 2 293 130 | 2 185 968 |
| Total equity | 2 054 822 | 2 244 149 | 2 428 897 | 2 816 533 | 2 861 144 |
| Calculated dividends | 99 039 | 0 | 0 | 0 | 250 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a company to see its connections.
The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.
Documents in the Register of Financial Statements16
- 2025 Správa audítora
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2025 Úč POD
- 2024 Správa audítora
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2024 Úč POD
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2023 Úč POD
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
- 2021 Úč POD · 12 pp.
- 2021 Úč POD
- 2021 Úč POD
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
- TT Pharma, s.r.o. · Šintava
- BIOPHARM SK spol. s r.o. · Rimavská Sobota
- GOLD & CREDIT, s. r. o. · Žiar nad Hronom
- MD-Pharm Slovakia, s.r.o. · Nitra
- SkinMedical s.r.o. · Kežmarok
- Medicontur s.r.o. · Nitra
- Merck Sharp & Dohme, s.r.o. · Bratislava - mestská časť Petržalka
- MEDANTE HOLDING, s. r. o. · Bratislava
- ELLA-CS International, s. r. o. v likvidácii · Bratislava - mestská časť Záhorská Bystrica
- VWR International s. r. o. · Bratislava - mestská časť Ružinov